Name: 14th International Conference on Arthritis
Start: 2023-10-09
End: 2023-10-11
Location: France

Renowned Speakers

We’ve invited the top most influential speakers from around the world to give inspirational talks and lead practical workshops.

Cristiano Sconza

Humanitas Research Hospital Italy

Arpit Patel

UK Royal Free NHS Foundation Trust UK

Galina Gridneva

V.A. Nasonova Research Institute of Rheumatology Russia

Mansoor Chaudhary

Our Lady of Lourdes Hospital Ireland

Helge Lundberg

Medical Director, Skjetten Medical Centre Norway

Biography

Luca Roncati

University of Modena and Reggio Emilia, Italy Italy

Biography

Malu Sreekumar

ANIIMS Porblair India

Gholam Ridha Al-Adeli

Medical School, Qatar University Qatar

Conference Information

Welcome Message

The organizing committee of Rheumatology Conferences 2023 is ecstatic to welcome all Doctors, Physicians, Rheumatologists, Orthopaedists, Immunologists, Researchers, Scientists, Nurses, Healthcare Providers, Leaders, Healthcare Professionals and Students to the “14th International Conference on Arthritis and Rheumatology”. The conference is scheduled on October 09-11, 2023 in Paris, France. Discussing recent and forthcoming advancements in the domains of rheumatology conferences 2023, arthritis 2023, and allied fields is the conference's main theme.

The Rheumatology Conferences 2023 will feature intellectual and insightful talks, discussions, debates, and exhibits from some of the most prestigious brands and companies. For three days, you will have an enriching experience that will help you build your network and brand.

Our conference is taking place in Paris, France, popularly referred to as the "The City of Light". It is also a well-known tourist destination with a variety of amazing and captivating attractions.

Join us in Paris for an educational and enjoyable experience!

Important Deadlines and Venue

Important Deadlines & Venue

Mark your calendar for the following important RHC 2023 Conferences deadlines

Abstract Submission Deadline (Extended): 30 July 2023. (*)
Final Paper Submission Deadline: 20 July 2023. (*)
Final Phase Early Bird Registration Deadline: 30th June 2023. (*)
Notification of Abstract Acceptance/ Rejection: 1-2 days.
Conference Dates: October 09-11 2023, Paris, France.

*By Midnight-11:59 pm London Time Zone

Join as group with minimum of 5 members and get 35% discount on total registration fee.

Exciting early bird registration perks awaits you. (Valid till 2nd phase early bird registration)

Venue and Accommodation: Millennium Hotel Paris Charles De Gaulle

Enjoy complimentary breakfast, free Wi-Fi, and the possibility of early check-in/check-out (depending on room availability). Rooms are available as single or double occupancy.

It would be greatly appreciated if you could send us a mail to rheumatologycongress@pulsusforums.com regarding any separate or additional accommodation bookings that you may need. Please include the details of your preferred package or desired number of nights, so that we can efficiently assist you with your arrangements with the personalized registration link.

Please be advised that in order to receive the confirmation receipt of your room reservation for the dates of your choice, prompt payment of the applicable fee is required.

To know more, visit: RHC 2023 Venue

Contact rheumatologycongress@pulsusforums.com for accommodation related queries.

Market Analysis

Global Rheumatology Therapeutics Market:

In the projection period of 2023 to 2028, the rheumatic therapeutics market is anticipated to develop at a CAGR of 2.23% and is projected to reach USD 39,463.29 million by 2028. The rheumatic therapeutics market analysis offers analysis and insights into the numerous elements that are anticipated to be present over the course of the forecast period as well as their effects on the market's expansion. The market for rheumatic treatments is expanding at an accelerated rate due to the rise in rheumatoid arthritis 2023 prevalence and other related disorders.

Rheumatoid Arthritis are becoming more common, fitness is becoming more popular around the world, and biopharmaceuticals are becoming more widely accepted, all of which are driving the growth of the rheumatology conferences 2023 therapeutics market. The market for rheumatic medicines is further impacted by the growing number of small molecules in the drug development pipeline because they are known to be less expensive than biologics. Additionally, the market for Rheumatology Conferences 2023 is favourably impacted by the rise in geriatric population, technical developments in the pharmaceutical business, rising investments in the healthcare sector, and spike in healthcare spending among the middle class. Additionally, in the projection period of 2021 to 2028, the rate of new biologic drug launches is expected to increase, along with approvals and the penetration of generic pharmaceuticals. These factors offer lucrative prospects to companies in the Rheumatology Conferences 2023 market.

On the other hand, high treatment costs and a growing market for biosimilar pharmaceuticals are projected to restrain the expansion of the Rheumatology Conferences 2023 sector. During the forecast period of 2021 to 2028, the rheumatology conferences 2023 therapeutics market is expected to face challenges related to the patent expiry of popular medications used to treat rheumatic illnesses.

Market Scope and Market Size:

Market segments for rheumatic medicines are created based on drug class, disease indication, and distribution method. The development of these segments will assist you in analysing the industries' sparsely growing segments and will give users useful industry overview and market insights to aid in the selection of key market applications. The rheumatology conferences 2023 therapeutics market is divided into nonsteroidal anti-inflammatory medications (NSAIDs) and disease-modifying anti-rheumatic therapies (DMARDs) based on drug class. The rheumatology conferences 2023 therapeutics market is divided into rheumatoid arthritis, osteoarthritis, gout, psoriatic arthritis, and ankylosing spondylitis based on the disease indication. The rheumatic therapeutics market is divided into hospital pharmacies, retail pharmacies, and online pharmacies based on the distribution channel.

Global Rheumatology Therapeutics Market Country Level Analysis:

The market for rheumatology conferences 2023 medicines is examined, and insights and trends regarding market size are given by nation, drug class, illness indication, and distribution channel, as previously said.

The U.S., Canada, and Mexico are included in North America's rheumatology conferences 2023 therapeutics market report, as are Germany, France, the United Kingdom, the Netherlands, Switzerland, Belgium, Russia, Italy, Spain, and Turkey, as well as the rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, and the rest of Asia-Pacific (APAC), as well as Saudi Arabia, the United Arab Emirates, South Africa, Egypt, Israel.

Due to its large aged population, widespread use of biologics and biosimilar medicines to treat moderate to severe rheumatoid arthritis, and sophisticated healthcare systems, North America dominates the global market for rheumatic treatments. In the forecast period of 2021 to 2028, Asia-Pacific is anticipated to experience the highest growth rate due to the region's high prevalence of rheumatoid arthritis and osteoarthritis, rising approval rates for biosimilar treatments for a variety of rheumatology conferences 2023 disorders, and rising per-capita healthcare costs.

Demand for Rheumatoid Arthritis Treatment is Increasing in the U.K:

The infrastructure of the British healthcare system is highly developed and heavily subsidized by the government. It has the potential to be the world's best healthcare system. The United Kingdom has the highest amount of expenditure in Europe, which is not surprising. The U.K. is acknowledged as a major market, and this status is likely to hold during the anticipated years.

Additionally, growing research activities, the existence of multiple large firms, and an increase in pipeline medications are creating a number of opportunities for stakeholders in the nation's Rheumatology Conferences 2023 business.

Innovation Key to Succeed in the German Pharmaceuticrthritis al Market:

One of the top countries in the world for producing medications is Germany. The nation's manufacturers are at a competitive advantage because they are creating products and using cutting-edge research to solve unmet problems.

They also continually spend in order to grow their business, which has led to a more encouraging pipeline. Additionally, businesses are focusing on creating innovative products in markets with a lot of unmet needs.

For instance, Bayer AG said in 2020 that it intended to invest around US$59 million in the construction of a new manufacturing and supply facility at Beijing Economic-Technological Development in order to expand its Beijing supply center.

Drive in Demand for Rheumatoid Arthritis Treatment:

For those who offer care for people with rheumatology conferences 2023, new technologies to increase the therapeutic potential of antibodies, such as bi-specific antibodies and novel targets like JAK enzymes, have created new options.

The majority of big players are working on combination DMARD therapy, and many of these projects utilize adalimumab, the most popular anti-rheumatic medication in the world, in conjunction with new or existing biologic medicines

Major Segmentation based on region:

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa (MEA)

Future Market Scenario:

An increase in the frequency of arthritis and related joint problems is driving up demand for rheumatoid arthritis treatments. As a result of the transition to an unhealthy lifestyle, rising metabolic problems, ageing, family history of joint diseases, and increased obesity, rheumatoid arthritis is on the rise. To strengthen their position in this market, manufacturers are concentrating on partnerships with other competitors.

Competitive Landscape and Market Share Analysis:

The competitive landscape for the rheumatology conferences 2023 therapeutics market provides information by competitor. The company's financials, revenue generated, market potential, investment in R&D, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance are among the details that are included. The aforementioned data elements are limited to the companies' market focus on rheumatic medicines.

Companies in the sector are seeking mergers and strategic alliances with other companies in order to boost their output and satisfy the demand of a burgeoning patient base. As an illustration, Pfizer and Lilly signed a collaboration agreement in 2020 to jointly develop and market tanezumab for the relief of osteoarthritis and cancer pain. As part of the deal, the companies agreed to equally split ongoing development costs. Pfizer and Imcyse, a clinical-stage biopharmaceutical firm with headquarters in Belgium, announced a research collaboration and license agreement for the possible treatment of rheumatoid arthritis (RA) via Imcyse's RA programme based on its Imotope technology in February 2021.

By launching new, technologically advanced items and receiving regulatory approval from various government bodies, manufacturers are focusing on broadening their product lines.

Leading companies operating in the market:

• Pfizer Inc.

• Sanofi S.A.

• Johnson & Johnson

• AbbVie Inc.

• Amgen Inc.

• Bristol-Myers Squibb Company

• F. Hoffman-La Roche AG

• Sun Pharmaceutical Industries Ltd.

• Cipla, Inc.

• Sobi Inc.

• Novartis AG

• UCB S.A.

Scientific Sessions

Session 1: RHEUMATOLOGY

Rheumatology 2023 is a discipline of medicine that deals with the study and therapy of rheumatic diseases. Rheumatologists are doctors who specialize in the field of rheumatology conferences 2023 and treat patients with rheumatic disorders. It is possible to categorize rheumatology conferences 2023 into two main categories: (1) the diagnosis and treatment of inflammatory illnesses that affect the joints and nearby tissues. (2) Osteoarthritis, mechanical and degenerative spinal problems, and soft-tissue conditions affecting the muscles, tendons, and ligaments around joints are conditions that may also affect the rest of the body, making them generalized disorders. Either of these categories may apply to neurological diseases such carpal tunnel syndrome and other nerve entrapments.

Associated Conferences

Associated Associations

Associated Journals

Associated Societies

Session 2: RHEUMATOID ARTHRITIS

The most prevalent form of autoimmune arthritis 2023 is rheumatoid arthritis (RA). The wrist, tiny joints in the hands and feet, and the shoulders and knees can all experience pain and swelling as a result of RA. The symptoms of RA can be reduced by treatments, which can also stop joint deterioration and deformities. Better long-term outcomes and a decreased need for joint replacement will follow from early therapy.

Associated Conferences

Associated Associations

Associated Journals

Associated Societies

Session 3: ORTHOPEDICS

Orthopedics 2023 is a medical field that focuses in identifying, treating, and preventing skeletal abnormalities, which include problems with the bones, joints, muscles, ligaments, tendons, nerves, and skin. The musculoskeletal system is made up of these components. You can move, work, and be active thanks to your body's complex musculoskeletal system, which is made up of bones, joints, ligaments, tendons, muscles, and nerves. Orthopedics 2023, which used to focus on treating young patients with spine and limb abnormalities, now treats patients of all ages, including infants with clubfeet, young athletes who need arthroscopic surgery, and elderly patients with arthritis. Orthopedists or orthopedic surgeons are the terms used to describe doctors who specialise in this field.

Associated Conferences

Associated Associations

Associated Journals

Associated Societies

Session 4: ANKYLOSING SPONDYLITIS

A chronic, inflammatory condition of the axial spine known as ankylosing spondylitis (AS) can cause a variety of clinical indications and symptoms. The most typical symptoms of the condition are growing spinal stiffness and chronic back pain. The condition is characterized by involvement of the spine, sacroiliac (SI) joints, peripheral joints, digits, and entheses. AS is characterized by reduced spinal mobility, postural irregularities, hip and buttock pain, peripheral arthritis, enthesitis, and dactylitis (sometimes known as "sausage digits"). This illness may potentially damage extra skeletal organs. The most prevalent extraarticular symptoms of AS are psoriasis (10%), acute anterior uveitis (25%–35%), and inflammatory bowel disease (up to 50%). A higher risk of cardiovascular disease is also linked to AS.

Associated Conferences

Associated Associations

Associated Journals

Associated Societies

Session 5: FIBROMYALGIA

A medical disorder known as fibromyalgia (FM) is thought to have an impact on the central nervous system. Widespread pain, which may be felt in one or more locations on the body, is the most typical symptom of fibromyalgia. The degree of the pain may change daily or even hourly, may vary from person to person, and may occasionally travel over the body. Other symptoms of fibromyalgia include fatigue, sleep issues, poor attention and memory, mood fluctuations, gastrointestinal issues (such as constipation or diarrhea), and an increased sensitivity to pressure and touch.

Associated Conferences

Associated Associations

Associated Journals

Associated Societies

Session 6: GOUT

Gout is a form of inflammatory arthritis 2023 that typically manifests as flare-ups that last a week or two before going away. Your big toe or a lower limb is where gout flares frequently start. High serum urate levels accumulate in your body, causing gout, which can lead to the formation of needle-shaped crystals in and around the joint. As a result, the joint develops arthritis and joint inflammation. Urate levels in the body rise when the body produces too much or eliminates too little of it. Numerous individuals who have high serum urate levels, meanwhile, won't get gout.

Associated Conferences

Associated Associations

Associated Journals

Associated Societies

Session 7: LYME DISEASE

The bacterium Borrelia burgdorferi and, in rare cases, Borrelia mayonii are the culprits behind Lyme disease. Through the bite of infected blacklegged ticks, it is transferred to people. Fever, headaches, exhaustion, and the distinctive skin rash known as erythema migrans are typical symptoms. Joints, the heart, and the nervous system can all get infected if untreated. The potential of exposure to infected ticks, physical signs (such as a rash), and symptoms all contribute to the diagnosis of Lyme disease. If carried out properly and according to proven procedures, laboratory testing is beneficial. A few weeks of medicines can successfully treat the majority of Lyme disease cases. Use of insect repellent, early tick removal, pesticide application, and reduction of tick habitat are measures to prevent Lyme disease.

Associated Conferences

Associated Associations

Associated Journals

Associated Societies

Session 8: CONNECTIVE TISSUE DISEASE

A set of illnesses affecting the protein-rich tissue that supports organs and other body parts are referred to as connective tissue diseases. Fat, bone, and cartilage are examples of connective tissue. These conditions frequently affect the joints, muscles, and skin, but they can also affect the eyes, heart, lungs, kidneys, gastrointestinal tract, blood vessels, and other organs and organ systems. The connective tissue is impacted by more than 200 diseases. The different categories each have different causes and symptoms.

Associated Conferences

Associated Associations

Associated Journals

Associated Societies

Session 9: OSTEOPOROSIS

Osteoporosis 2023 is a bone disease that develops when bone quality or structure deteriorates, bone mineral density declines, or when bone mass decreases. This may result in a loss of bone density and an elevated risk of fractures (broken bones). Osteoporosis is referred to as a "silent" illness because it frequently goes unnoticed until a bone is broken, and sometimes even then. Osteoporosis is the main factor in fractures in elderly men and postmenopausal women. Any bone can break; however, hip, spine, and wrist vertebrae are the most frequently broken bones.

Associated Conferences

Associated Associations

Associated Journals

Associated Societies

Session 10: BEHCET DISEASE

Recurrent oral aphthous ulcers, vaginal ulcers, and uveitis are the three symptoms that define Behçet illness, a rare vasculitic disorder. The systemic symptoms can vary. The largest morbidity is associated with ocular disease, followed by vascular disease, which is typically caused by active vasculitis. Up to 75% of Behcet illness patients might develop cutaneous signs, which can take the form of nodules, erythema nodosum, or acneiform lesions. It might be challenging to distinguish Behçet illness from active inflammatory bowel disease due to the severity of the GI symptoms. Its ability to affect tiny, medium, and large vessels makes Behçet disease distinct from other vasculitides.

Associated Conferences

Associated Associations

Associated Journals

Associated Societies

Session 11: OSTEOARTHRITIS

The majority of persons who suffer from osteoarthritis 2023, sometimes referred to as OA, are in their middle to late years of life. Although it is frequently referred to as "wear and tear" of the joints, we now understand that osteoarthritis is a disease that affects the entire joint, including the ligaments, bone, and cartilage. It is not quite correct to suggest that the joints are just "worn out," despite the fact that it is more common in older persons. The bone alterations of the joints, the breakdown of tendons and ligaments, the breakdown of cartilage (the tissue that cushions the ends of the bones between joints), and varying degrees of inflammation of the joint lining are its defining characteristics (called the synovium).

Associated Conferences

Associated Associations

Associated Journals

Associated Societies

Session 12: PSORIATIC ARTHRITIS

Psoriasis is an autoimmune illness that causes scaly, red, and white patches on the skin as the immune system begins to target skin cells. Psoriatic arthritis, another autoimmune illness in which the immune system starts to produce inflammation in the joints, can occasionally occur in persons with psoriasis and results in painful, stiff, and swollen joints. Similar to psoriasis, the intensity of psoriatic arthritis symptoms varies from person to person. Any joint in the body may be impacted by psoriatic arthritis, whether there are one or more affected joints. Dactylitis, a disorder where the fingers and toes look like sausages, is common. Nail pitting may be visible in the fingernails and toenails as well.

Associated Conferences

Associated Associations

Associated Journals

Associated Societies

Session 13: SPONDYLOARTHRITIS

An assortment of inflammatory illnesses known as spondyloarthritis 2023 cause arthritis. Spondyloarthropathy, or SpA for short, is another name you may encounter. Because it also results in inflammation in places known as entheses where ligaments and tendons join to bones, it differs from other types of arthritis. Your bones are connected to one another by ligaments, and your muscles are connected to your bones by tendons. Lower back discomfort, peripheral joint arthritis, such as that in the arms, legs, eye issues, and even inflammatory bowel illness are all frequently brought on by spondyloarthritis (IBD).

Associated Conferences

Associated Associations

Associated Journals

Associated Societies

Session 14: Arthritis

The term "Arthritis 2023" is frequently used to refer to any condition that affects the joints, despite the fact that joint inflammation is a symptom or indicator rather than a precise diagnosis. Where two bones touch, like in your elbow or knee, are joints. Different forms of arthritis exist. Other organs, such as your eyes, heart, or skin, may also be damaged by several disorders that cause arthritis. Fortunately, the majority of people with arthritis may lead active, useful lives because of modern medicines.

Associated Conferences

Associated Associations

Associated Journals

Associated Societies

Session 15 :SYSTEMIC LUPUS ERYTHEMATOSUS

Multiple organs or organ systems in the body may become inflamed as a result of SLE, either acutely or persistently. Contrarily, cutaneous lupus (CLE) affects only the skin, albeit it can eventually lead to SLE in certain cases. Certain prescription drugs may result in drug-induced lupus. Though it shares many of the same symptoms as SLE, it rarely has a negative impact on vital organs and goes away roughly six months after treatment is stopped. Neonatal lupus, which only affects infants, is not the genuine condition. After six months, the majority of neonatal lupus symptoms will be gone.

Associated Conferences

Associated Associations

Associated Journals

Associated Societies

Session 16: Pediatric Rheumatology

Pediatric Inflammatory illnesses of the musculoskeletal system and other autoimmune diseases in children and adolescents are the focus of the medical specialty known as pediatric rheumatology. Juvenile idiopathic arthritis (JIA) is the most prevalent rheumatic condition in children, but Kawasaki disease, juvenile dermatomyositis, and systemic lupus erythematosus are also common. We also treat kids with PFAPA syndrome and other autoinflammatory syndromes as well as illnesses with recurring fever. Osteoporosis and osteogenesis imperfecta are two bone diseases.

Associated Conferences

Associated Associations

Associated Journals

Associated Societies

Session 17: Rheumatic Heart Disease

A disorder known as rheumatic heart disease occurs when rheumatic fever permanently damages the heart valves. After an untreated or inadequately treated streptococcal infection, such as strep throat or scarlet fever, the heart valve damage may begin. An inflammatory state brought on by an immunological reaction can lead to ongoing valve deterioration. Rheumatic fever, an inflammatory condition that can damage numerous connective tissues, particularly in the heart, joints, skin, or brain, is the root cause of rheumatic heart disease. Over time, the heart valves may become damaged and irritated. This can cause the heart valve to constrict or leak, making it more difficult for the heart to operate normally. Heart failure may ensue from this, which could take years to manifest.

Associated Conferences

Associated Associations

Associated Journals

Associated Societies

Session 18: GENERAL MEDICINE

General medicine is a branch of medicine that deals with the prevention, diagnosis, and treatment of a variety of acute and chronic illnesses that affect various body areas. All types of illnesses are covered by general medicine.

Associated Conferences

Associated Associations

Associated Journals

Associated Societies

Session 19: Autoimmunity

Your immune system attacks your body when you have an autoimmune disease. The immune system typically protects against viruses and germs. When it detects these outside invaders, it unleashes a massive army of fighter cells to engage them. Normally, your immune system can distinguish between your own cells and foreign cells. When you have an autoimmune disease, your immune system misidentifies a portion of your body, such as your skin or joints, as alien. Autoantibodies, a class of proteins, are released and assault healthy cells. Some autoimmune illnesses only affect one organ. Pancreas damage from type 1 diabetes. Other conditions, such as systemic lupus erythematosus (SLE), or lupus, can have a global impact.

Associated Conferences

Associated Associations

Associated Journals

Associated Societies

Session 20: Autoinflammatory diseases

The autoinflammatory disorders are a set of illnesses that, in their most basic manifestations, show up as recurring fevers, strong acute phase reactions, and a tendency toward skin, joint, and serosal surface inflammation as well as other organ involvement, including nervous system involvement. These conditions don't have high-titer autoantibodies, which are typical of autoimmune diseases. Autoinflammatory disorders are characterized by dysregulation of the cells and molecular cascades essential to innate immunity, and this dysregulation is the primary pathophysiologic role of the innate immune system in these diseases.

Associated Conferences

Associated Associations

Associated Journals

Associated Societies

Session 21: Genetic diseases of connective tissue

A sizable group of hereditary illnesses with such a considerable of genetic and clinical variety are HCTD. These diseases are typically brought on by errors in the genes that produce the main proteins that make up connective tissue, like collagen and elastin. Some of these ailments alter the way this matrix functions, the shape of the body, or both. The term "HCTD" refers to more than 200 different conditions. The most well-known HCTDs include osteogenesis imperfecta, Ehlers-Danlos syndromes, and Marfan and associated disorders. There are numerous categories and sub-groups for each of these syndromes. These diseases frequently share symptoms and treatments. Newer varieties of HCTDs are being found as genetic technologies progress. The body's connective tissue is the most prevalent and plentiful main tissue.

Associated Conferences

Associated Associations

Associated Journals

Associated Societies

Session 22: Hemarthrosis

Hemarthrosis, or joint bleeding, is brought on by diseases like haemophilia, physical trauma, or other circumstances. Pain, edoema, and stiffness in the joints are common symptoms, and it can take weeks or months to get better. Since prolonged contact to blood might harm your joints' cartilage, treatment is necessary.

Associated Conferences

Associated Associations

Associated Journals

Associated Societies

Session 23: Osteonecrosis

Osteonecrosis, also known as aseptic necrosis or avascular necrosis (AVN), is the loss of bone cells as a result of reduced blood supply. It may cause discomfort and bone collapse in certain locations. Degenerative arthritis 2023, commonly known as osteoarthritis, of surrounding joints, most frequently the hips and knees, can result from this bone collapse. Shoulders, hands, and feet are areas that are less frequently impacted. Osteonecrosis can very rarely happen in the jaw. Gum tissue ulcers (sores), exposed jawbone, and pain may occur from this.

Associated Conferences

Associated Associations

Associated Journals

Associated Societies

Session 24: Pain in Rheumatic Diseases

Almost typically, rheumatic discomfort is localized in arthritis 2023. It might just affect a particular area of the body (like the shoulder girdle) or a single structure in numerous locations (e.g., the peripheral joints). The process of localizing the symptoms is the most significant component of the musculoskeletal history from the perspective of specific diagnosis of rhuematoid arhtritis.

Associated Conferences

Associated Associations

Associated Journals

Associated Societies

Session 25: Information Technology in Rheumatology

Technology's contributions to self-management, clinical treatment, and research offer tremendous prospects for improving both individual and societal health and well-being. The road to successful adoption and use, however, is paved with significant obstacles, such as persuading EHR providers to develop systems to support disease-specific needs, standardizing data items across geographies with trusted extraction and reuse of health data outside of direct care, upfront investment for longer-term gain, maintaining motivation for sustained engagement in data collection, ensuring interoperability, and ensuring equitable access to digital services and digital literacy. However, there are a lot of possible advantages. In clinical care and research, we are starting to see meaningful changes. It is worthwhile to work toward this future in treating rheumatoid arthritis.

Associated Conferences

Associated Associations

Associated Journals

Associated Societies

Session 26: Benefit/risk of new drugs for rheumatoid arthritis

1. NSAIDs (nonsteroidal anti-inflammatory medications) reduce inflammation and discomfort. Some of them are available over-the-counter, including ibuprofen and naproxen sodium. Others, such as COX-2 inhibitors, which may be better on your stomach, require a prescription.

2. Prednisone and other corticosteroids work swiftly to control inflammation. Doctors restrict the dosage and duration of use since these potent medications have potent negative effects.

3.Disease-modifying antirheumatic medications (DMARDs) can change how rheumatoid arthritis develops and stop tissue and joint damage. They inhibit the actions of substances that are released when your immune system inadvertently targets your joints.

4. Biologics - The majority of today's medications are biologics, which means they are derived from human genes. These effective knockoffs could tame an overactive immune system.

Associated Conferences

Associated Associations

Associated Journals

Associated Societies

Session 27: Spinal Disorders

An irregularity of the spine anywhere, from the neck to the lower back, is referred to as a spine condition. Numerous spine diseases can be uncomfortable and, in some circumstances, degenerative because the spinal column serves as your body's primary support and safeguards your spinal cord. Depending on the specific illness, several symptoms are present in spine problems. Since the spine serves as the body's primary support, problems of the spine frequently have an impact on other body regions. Depending on the type of spine issue, treatment for these conditions differs from person to person.

Associated Conferences

Associated Associations

Associated Journals

Associated Societies

Session 28: Artificial Intelligence Treatments

Artificial intelligence (AI) is the term used to describe the use of technology to simulate human cognitive abilities such as logical thinking and intelligent behavior. Although AI-based technologies are widely used in a variety of healthcare contexts for functions like image analysis and diagnosis, its full potential to direct rheumatic disease management is still untapped. In rheumatic disorders, AI techniques are emerging to help in early diagnosis and prediction of disease progression, although these have not yet entered clinical practice. Many potential biological markers of response to anti-TNFs have been established, and rheumatology 2023 researchers are investigating AI methods for therapy response prediction. This research is still in the exploratory phase, though.

Associated Conferences

Associated Associations

Associated Journals

Associated Societies

Session 29: Plastic Surgeries in treatment of Rheumatoid Arthritis

Daily tasks can seem like a hassle because of the rheumatoid arthritis (RA)-related joint discomfort, stiffness, and edoema. If untreated, RA can also affect how well the knees, ankles, elbows, hips, and shoulders function normally. The hands and fingers may become unable to grip, grasp, and pinch as a result of RA, which tends to get worse over time. Although there is no proven treatment for RA, medications can lessen symptoms, enhance function, and lessen joint deterioration. Plastic surgery, albeit unanticipated, can be a useful therapy option when medications alone are insufficient. Plastic surgery can restore the look and appearance of the hands in addition to addressing the symptoms of RA.

Associated Conferences

Associated Associations

Associated Journals

Associated Societies

Session 30: Hip, Knee and Shoulder Replacement Surgery

A multitude of illnesses, such as arthritis 2023, fractures, or other diseases, can damage the articular cartilage, which lines the ends of the bones and causes joint pain. A joint replacement can improve a patient's mobility and lessen pain. Parts of an arthritic or diseased joint are surgically removed and replaced with a prosthesis in a total joint replacement (a metal, ceramic or plastic device). The prosthesis mimics the joint's natural, healthy mobility. The most common joint replacement surgeries are on the hips and knees, but elbow, ankle, wrist, and shoulder can also be treated. Hip and knee replacements, both partial and complete, can be done using robotic surgery.

Associated Conferences

Associated Associations

Associated Journals

Associated Societies

Session 31: Current Scenario of Global Healthcare

A high quality of life is fundamentally dependent on health. Our ability to enjoy life directly depends on not being unwell or injured. A rising corpus of empirical data indicates that, on a macro level, healthcare investments have a significant impact on health outcomes. Furthermore, as one would anticipate, the evidence points to significant health gains from spending on healthcare at low baseline levels. This suggests that, if properly targeted and managed, foreign resources directed through development aid for health have the potential to significantly reduce worldwide inequities in living standards.

Associated Conferences

Associated Associations

Associated Journals

Associated Societies

About Conference

Rheumatologists, orthopaedists, doctors, nurses, healthcare providers, surgeons, students, nurses, researchers, scientists, entrepreneurs, leaders, presidents, founders, CEO's, business delegates, and young researchers and experts from hospitals, universities, businesses, and research labs are among the attendees expected at the Rheumatology Conferences 2023. We want to provide a relaxed yet energetic environment where people can exchange ideas and have fruitful discussions about the problems the Rheumatology Conferences 2023 sector is now facing as a whole as well as possible solutions to these problems.

Our conference will give professionals and students a fantastic platform to present their research and interests and to establish themselves on the international scene. Our keynote and plenary speakers will share with us their most recent projects, any difficulties they encountered, as well as their overall experiences. The conference's theme for the Rheumatology Conferences 2023 is "Opportunities and Challenges for Future Innovative Rheumatology and Arthritis Treatments."

Why Attend?

Rheumatology Conferences 2023 is a sought-after congress by universities, industries, hospitals and healthcare organisations. It is a fantastic platform to exchange knowledge and network with fellow researchers from around the globe. The Rheumatology Conferences 2023 includes Keynote speeches, Oral presentations, Poster presentations, Workshops, Symposiums, and special sessions for Supporting associations.

The conference venue Paris is home to numerous iconic landmarks, including the Eiffel Tower, Notre-Dame Cathedral, and the Louvre Museum, as well as countless charming cafes, shops, and restaurants. With its beautiful parks, winding streets, and romantic atmosphere, Paris is the perfect location for conferences, meetings, and other events. The city also has a well-developed transportation system, making it easy for visitors to get around and explore all that Paris has to offer. Overall, Paris is an excellent choice for anyone looking for a venue that combines history, culture, and charm.

Rheumatology Conferences 2023 will definitely be the best platform to connect with the top experts from the world and to also discuss the growing trends in the field of Rheumatology Conferences 2023, Arthritis, and related areas in various parts of the globe.

We assure you that you will have an enriching and unparalleled experience at our Conference!

Who can join us?

Rheumatologists
Orthopaedists
Doctors
Healthcare Providers
Surgeons
Students
Nurses
Researchers
Scientists
Caregivers
Institutions, Societies & Associations
Entrepreneurs
Corporate Leaders
Sales Representatives
Companies
You!

About Venue

Paris, also known as the City of Lights, is the capital of France and one of the most popular tourist destinations in the world. The city is famed for its romantic atmosphere, stunning architecture, world-class cuisine, and rich history and culture.

Some of the top attractions in Paris include the Eiffel Tower, the Louvre Museum, the Notre-Dame Cathedral, the Champs-Élysées, and the Palace of Versailles. Visitors can also explore the charming streets of Montmartre, stroll along the Seine River, or enjoy a picnic in one of the city's many beautiful parks.

Paris is also known for its incredible food and wine. Visitors can indulge in traditional French dishes such as escargots, foie gras, and coq au vin, or sample some of the city's famous pastries and desserts. The city is also home to some of the world's best wine bars and tasting rooms, where visitors can sample some of France's finest wines.

In addition to its attractions and cuisine, Paris is also a center of art, fashion, and culture. The city is home to numerous museums, galleries, and theaters, as well as some of the world's top fashion designers and luxury brands.

Overall, Paris is a must-visit destination for anyone interested in history, culture, art, food, or romance. With its endless attractions and charming atmosphere, the city is sure to captivate and inspire visitors from all over the world.

Top 10 must visit spots in Paris:

1. Eiffel Tower

2. Louvre Museum

3. Notre-Dame Cathedral

4. Champs-Élysées

5. Montmartre

6. Palace of Versailles

7. Musée d'Orsay

8. Sainte-Chapelle

9. Luxembourg Gardens

10. Opera Garnier

These are just a few of the many amazing sights to see in Paris. Whether you're interested in art, history, or just want to soak up the city's charm, Paris has something to offer everyone.

Past Conference Report

For their contributions to the success of Rheumatology Conferences 2022, we would like to thank all of our fantastic keynote speakers, Webinar participants, students, associations, media partners, and attendees.

The Rheumatology Conferences 2023 conference with the theme of "Scientific advancements in Rheumatology and Orthopaedic Surgery" was held on April 27, 2022.

Famous keynote speakers from a range of prominent organisations and institutions made their presence felt and catered to the social occasion during the presentations, discussions, and debates, which were a remarkable feat.

The painstakingly planned Rheumatology Conferences 2023 is centred on a key idea that will lay the groundwork for upcoming scientific breakthroughs.

Visa Support

Planning a trip to Paris, France? Attend our Conference - RHC 2023!!!

Issue with VISA??

To support the participants in his/her VISA application process, we issue each participant with VISA supporting documents. The documents are as follows:

· The official letter of Invitation

· The official letter of the Abstract Acceptance

· The receipt of the payment

· Visa Covering Letter

Points to be noted:

· Visa Support Letter (the official letter of invitation) will be issued only after you have successfully registered and paid for your conference

· Visa Support Letters can be issued only for the person accepted to attend the conference.

· Visa Support Letters will be issued only via email in PDF format

Please contact the Program Manager:

Ms. Sara Langford via rheumatologycongress@pulsusforums.com to arrange for a Visa Support Letter.

Kindly provide us with the following details to provide you with VISA SUPPORT LETTERS:

· Your name as mentioned on your passport

· A scanned copy of your Passport

· And Abstract Acceptance letter for Presenters

One can make the payment through the following Payment Methods:

· Payment Gateway/Stripe

· Pay Pal

· Bank to Bank transfer

Having trouble in registration?

Please contact Ms. Sara Langford via rheumatologycongress@pulsusforums.com. The team of RHC 2023 will provide you the INVOICE for the requested price with which he/she can make the Bank-to-Bank transfer.